Glossary: SERMS

SERMs are a class of compounds that selectively bind to estrogen receptors, acting as either agonists or antagonists depending on the tissue type. They’ve been widely used in medicine – and more recently studied in performance and hormone-related contexts. But what exactly are SERMs, and how do they differ from SARMs or anabolic steroids?

What Are SERMs?

SERM stands for Selective Estrogen Receptor Modulator.
These compounds interact with estrogen receptors (ERs), not the Androgen Receptors, in different tissues of the body – but here’s the key:

• In some tissues (like bone or liver), they may mimic estrogen (agonist effect).
• In other tissues (like breast or uterus), they may block estrogen (antagonist effect).

This tissue-selectivity makes SERMs powerful therapeutic agents for managing estrogen-related conditions without universal estrogenic activity.

According to the National Institutes of Health:
“SERMs are unique in that they may act as an estrogen receptor agonist in one tissue while acting as an antagonist in another.”
(PubMed – PMC4154886)

Common Examples of SERMs

These compounds are prescription-only and are regulated as medicines in most jurisdictions.

How SERMs Work

Estrogen receptors are nuclear transcription factors.
When estrogen or a SERM binds, it changes gene expression – either activating or suppressing target genes.

SERMs modify this activity by:

• Binding selectively to ERα or ERβ
• Altering receptor shape, which changes the recruitment of co-activators or co-repressors
• Creating tissue-specific outcomes, depending on receptor subtype distribution

This is how the same compound can stimulate bone density but inhibit breast tissue growth.

Want to go deeper? See:

• PMC4995266 – Selective Estrogen Receptor Modulators
• PubMed 19387883 – Pharmacology and clinical applications of SERMs

SERM vs SARM – What’s the Difference?

A common confusion, especially in the fitness or research space, is SERMs vs SARMs.

Androgen receptor modulators (SARMs) aim to mimic testosterone, whereas SERMs modulate estrogen response – both are selective, but act on very different systems.

Safety, Side Effects & Regulation

While SERMs have medical uses, they’re not without risk.
Potential side effects include:

• Hot flashes
• Blood clots (DVT/PE)
• Endometrial effects (especially with tamoxifen)
• Visual disturbances (clomiphene)

In the UK, US and EU, SERMs like tamoxifen and clomiphene are classified as prescription-only medicines.
You cannot legally purchase or sell them for general use without medical oversight.

For UK context: see MHRA Human Medicines Regulations

Why Are SERMs Used in Research?

In hormone-focused studies – especially involving testosterone, LH, FSH, or fertility – SERMs serve as tools to modulate the hypothalamic-pituitary-gonadal axis (HPG axis). Example uses:

• Clomiphene or Enclomiphene to boost endogenous testosterone
• Tamoxifen to mitigate estrogen rebound during post-cycle therapy (PCT)
• Raloxifene for studying bone density preservation in estrogen-deficient models

These compounds allow scientists to control estrogen pathways precisely, which is key in endocrine and reproductive research. Research-grade enclomiphene is stocked in our SARMs shop.

Summary: What to Remember About SERMs

SERMs are powerful, selective tools – both in the clinic and the lab. Whether you’re a researcher studying endocrine pathways or someone trying to understand PCT protocols, knowing how SERMs work is foundational.

Want to explore more? See our glossary on SARMS Guide

Written by

Victoria Atkinson, DPhil · Freelance

Freelance science journalist

Victoria Atkinson is a freelance science journalist based in York. Victoria specialises in chemistry and its interface with the natural and human-made worlds, and has written for Chemical and Engineering News, Live Science, Physics World and Technology Networks. Victoria was formerly a science content developer at the University of Oxford and a member of the Chemistry World editorial team, and was nominated for the Association of British Science Writers Newcomer of the Year award in 2023.